With favorable cannabis-growing conditions, Colombia is quickly emerging as an industry hot spot. In fact, the country could capture as much as a fifth of a global market that could be worth $40 billion a year, according to Reuters.
“Colombia is wooing foreign investors, talking up its potential in the new era of peace as a resource-rich country with a business-friendly regulatory environment,” noted The Globe and Mail. “Colombia has the ideal climate for cannabis, with the evenly split 12 hours of light and dark each day that the plant prefers, a pool of low-cost labor and easily-transferable expertise and infrastructure from a large cut-flower export business.”
That could be quite beneficial to several cannabis stocks with exposure including Blueberries Medical Corp. (CSE:BBM)(OTC:BBRRF), Khiron Life Sciences Corporation (OTC:KHRNF) (TSXV:KHRN), and PharmaCielo Ltd. (OTC:PHCEF)(TSXV:PCLO).
Colombian-based producer, Blueberries Medical Corp (BBM), for example, just announced its common shares are now listed on the Frankfurt Stock Exchange (FSE) trading under ... Click here to view full article